Pricing Log in Create free account

InfuSystems Holdings, Inc. (INFU) vs Standard BioTools Inc. (LAB)

InfuSystems Holdings, Inc. and Standard BioTools Inc. are both Medical Devices companies. InfuSystems Holdings, Inc. and Standard BioTools Inc. are of similar size ($277.2M and $258.5M). Standard BioTools Inc. trades at the lower P/E: 2.9× against 31.7×. Standard BioTools Inc. grew revenue faster over the last twelve months: 30.2% against 2.47%. Standard BioTools Inc. has the higher net margin (100.4% vs 5.96%) and the lower return on invested capital (−93.9% vs 10.6%). Across the 21 metrics below, Standard BioTools Inc. leads on 12 and InfuSystems Holdings, Inc. on 9.

Valuation

Metric INFU LAB Medical Devices median
P/E 31.74 2.86 23.22
P/S 1.87 2.91 2.34
P/B 4.52 0.46 2.33
Price to free cash flow 124.73 n/m 23.72
EV/EBITDA 10.80 2.42 11.54
EV/Sales 2.00 (2.66) 2.24
Earnings yield 3.15% 34.92% (10.09%)
Free cash flow yield 0.80% (36.21%) (8.47%)

Profitability

Metric INFU LAB Medical Devices median
Gross margin 57.45% 50.49% 56.01%
Operating margin 9.26% (112.85%) (15.03%)
Net margin 5.96% 100.37% (20.40%)
Free cash flow margin 10.56% (97.61%) (7.24%)
Return on equity 15.03% 17.61% (15.32%)
Return on assets 8.61% 14.34% (19.72%)
Return on invested capital 10.55% (93.89%) (10.33%)

Growth

Metric INFU LAB Medical Devices median
Revenue growth (TTM) 2.47% 30.23% 8.80%
EPS growth (last fiscal year) 181.82% 61.54% 29.03%
Revenue growth, 5-year CAGR 8.05% (9.19%) 15.47%
Net income growth, 5-year CAGR (17.49%) 0.00% 0.00%

Health

Metric INFU LAB Medical Devices median
Debt to equity 0.35 0.00 0.07
Current ratio 2.50 9.10 2.50
Net debt to EBITDA 0.65 1.84 0.49

Dividend

Metric INFU LAB Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric INFU LAB Medical Devices median
Market cap 277.24m 258.47m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack